What is CV's market cap?

$364.49M, based on the Nov 4 close of $6.85.

Does CapsoVision pay a dividend?

No regular cash dividend has been paid in the last year.

How much of CV is sold short?

2.2M shares, 6.4% of float, as of Oct 15, 2026.

What sector is CV in?

Healthcare, in the Electromedical Equipment industry.

NASDAQ · CVHealthcareElectromedical Equipment

CapsoVision, Inc. Common Stock (CV)

$6.85+2.24%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$6.99▲ 46.23% in range

Nov 3, 2025Low $4.59 · High $14.42Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

CapsoVision closed at $6.85 on Nov 4, up 2.24%, 52.5% below its 52-week closing high. Volume of 136.0K shares was 1.06× its 20-day average (close to normal).

Split-adjusted performance: +5.4% over one month, -2.3% over six months, +43.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $3.64M, with a net margin of -205.4%.

Short interest was 2.2M shares at the Oct 15 settlement, up 3.7% from the prior report (6.4% of float, 21.2 days to cover).

Market cap$364.5M53.2M shares

Revenue · quarter$3.6M—

Diluted EPS$-0.15—

P/E · TTM—P/S 26.2×

Net margin-205.4%Gross 51.4%

Dividend yieldNone$0.23 last paid

52-week range4.59 – 14.42−52.5% from high

Volume136.0K1.06× 20-day avg

Volatility · 60d49.3%Annualised

Short % of float6.4%21.2 days to cover

Net cash$9.1MCash $9.1M

Next earnings—Not scheduled

Split-adjusted performance

1W −3.0%1M +5.4%3M −0.7%6M −2.3%YTD −35.9%1Y +43.3%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum43

Revenue growth—

Net margin21

Value (low P/E)—

Size67

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →

Shares short2.2M+3.7% vs prior

Days to cover21.2Settled Oct 15

% of float6.4%

Short vol. 10d74.6%of daily volume

Closest peers by size in Electromedical Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
CVCapsoVision	$6.85	+2.24%	−2.3%	—	−205.4%	—	$364.5M
ELMDElectromed	$28.01	+4.83%	+8.0%	+11.6%	17.5%	20.5	$232.1M	Compare
CBLLCeriBell	$27.39	−3.11%	+35.9%	+29.9%	−72.8%	—	$1.05B	Compare
VANIVivani Medical, Inc. Common Stock (DE)	$1.07	+1.90%	−14.4%	—	—	—	$96.5M	Compare
STXSStereotaxis	$0.9572	+13.55%	−50.1%	−12.8%	−62.3%	—	$95.9M	Compare
NRXSNeuraxis	$6.86	+4.26%	−22.1%	+115.7%	−118.1%	—	$86.1M	Compare
OMOutset Medical	$4.44	+6.99%	−1.6%	+0.7%	−56.8%	—	$83.5M	Compare
CNMDCONMED	$53.66	+13.61%	+43.8%	−0.7%	5.9%	21.8	$1.60B	Compare
HYPRHyperfine	$0.7503	+8.36%	−56.6%	+44.8%	−238.2%	—	$79.6M	Compare

News about CapsoVision

All news →

No recent articles focused on CapsoVision.

Quick answers

What does CapsoVision do?: CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images.
What is CV's market cap?: $364.49M, based on the Nov 4 close of $6.85.
Does CapsoVision pay a dividend?: No regular cash dividend has been paid in the last year.
How much of CV is sold short?: 2.2M shares, 6.4% of float, as of Oct 15, 2026.
What sector is CV in?: Healthcare, in the Electromedical Equipment industry.

About CapsoVision

CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

HQ: Saratoga, CA99 employeesListed Jul 2, 2025capsovision.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology